What is Metabolic Technologies?
Metabolic Technologies, Inc. (MTI) operates as a specialized research entity dedicated to the formulation of high-efficacy nutritional ingredients. By focusing on the intersection of sports performance and physiological health, the company provides essential components for the broader health and fitness industry. As a subsidiary of TSI Group Ltd., MTI leverages institutional backing to maintain a rigorous standard of clinical validation, ensuring that its product portfolio meets the evolving demands of athletes and health-conscious consumers seeking muscle-centric wellness solutions.
How much funding has Metabolic Technologies raised?
Metabolic Technologies has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Metabolic Technologies
PPP
Public-Private Partnership
What's next for Metabolic Technologies?
Following this major strategic investment, Metabolic Technologies is well-positioned to accelerate its research and development pipeline. The infusion of capital will likely facilitate the expansion of its proprietary ingredient catalog and strengthen its competitive moat in the global sports nutrition market. By prioritizing evidence-based outcomes, the company is poised to scale its operations, potentially exploring new distribution channels and deepening its integration within the TSI Group ecosystem to drive long-term value creation.
See full Metabolic Technologies company page
